Itamar Medical INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$4.4Mgeneral payments (2019-2025)
$158Kresearch payments (2019-2025)
4,479clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $615K
2020 $558K
2021 $743K
2022 $1.0M
2023 $512K
2024 $477K
2025 $482K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Sleep Medicine (Internal Medicine) $2.4M
Pulmonary Disease $722K
Clinical Cardiac Electrophysiology $464K
Cardiovascular Disease $454K
Advanced Heart Failure and Transplant Cardiology $48K
Critical Care Medicine (Internal Medicine) $33K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Chandra Matadeen-Ali Glen Mills, PA Sleep Medicine (Internal Medicine) $2,300,113.02
Alan Schwartz Baltimore, MD Pulmonary Disease $694,478.36
Amir Lerman Rochester, MN Cardiovascular Disease $360,683.21
Elad Anter Boston, MA Clinical Cardiac Electrophysiology $316,273.01
Andrea Natale Austin, TX Clinical Cardiac Electrophysiology $76,413.29
Omar Burschtin New York, NY Sleep Medicine (Internal Medicine) $68,770.32
Atul Malhotra San Diego, CA Sleep Medicine (Internal Medicine) $60,094.63
Daniel Bensimhon Greensboro, NC Advanced Heart Failure and Transplant Cardiology $43,826.66
Rodney Horton Austin, TX Clinical Cardiac Electrophysiology $36,262.00
Matthew Schmitt Atlanta, GA Critical Care Medicine (Internal Medicine) $27,995.04

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.